BONUSCAP-ZERTIFIKAT - FRESENIUS Share Price

Certificat

DE000HD2QT35

Real-time BOERSE MUENCHEN 08:45:59 29/05/2024 BST
44.36 EUR +0.34% Intraday chart for BONUSCAP-ZERTIFIKAT - FRESENIUS
Current month+11.84%
1 month+14.89%
Date Price Change
29/05/24 44.36 +0.34%
28/05/24 44.21 +0.09%
27/05/24 44.17 +0.48%
24/05/24 43.96 +3.70%
23/05/24 42.39 +3.31%

Real-time BOERSE MUENCHEN

Last update May 29, 2024 at 08:45 am

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD2QT3
ISINDE000HD2QT35
Date issued 16/02/2024
Strike 48
Maturity 20/09/2024 (115 Days)
Parity 1 : 1
Emission price 34.03
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 44.43
Lowest since issue 26.85
Spread 0.03
Spread %0.07%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.23 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.64%
Consensus